South San Francisco's biotech corridor just scored one of its splashiest tenants. Elon Musk's Neuralink has leased the entire five-story life-science building at 499 Forbes Boulevard, taking roughly 144,000 square feet and planting a very public flag in the city’s lab landscape. The blockbuster deal arrives as Bay Area life-science real estate slowly claws back from a post-pandemic glut of vacant labs and overbuilt space.
As noted in a Q3 2025 market overview from Newmark, Neuralink signed for about 144,200 square feet at 499 Forbes, a Class-A facility configured for advanced labs, clean rooms and precision manufacturing. Neuralink, which is based in nearby Fremont and is developing implant technology intended to restore basic function for people with spinal-cord injuries, will use the site for engineering, clinical operations and specialized production.
Building's backstory and market shakeout
The five-story property was originally leased by InterVenn Biosciences in 2022, but the startup canceled its lease in 2023 amid industry-wide cost-cutting, as reported by the San Francisco Business Times. That retreat left one of South City’s newer lab assets sitting empty and underscored how fast the market cooled after a multi-year building boom.
Other local deals underline demand
Smaller transactions and renewals suggest demand is picky but still alive. Twist Bioscience renewed roughly 93,971 square feet at 681 Gateway Boulevard, according to a Q4 market summary from Cresa. Tenants are gravitating toward spaces that can be quickly retrofitted for specialized workflows, even as net absorption across the Peninsula remains uneven.
What industry watchers say
This is a "major company at the convergence of AI and biotech, indicating the future direction of the economy,” David Hosler, a vice president at Eastdil Secured, told CoStar, where judges also honored the transaction with a 2026 Impact Award. Judges and local brokers say deals of this scale demand intricate engineering coordination, secure infrastructure and high-power systems that only a limited number of Bay Area properties can provide.
What to watch next
Watch whether Neuralink’s build-out triggers conversions of idle lab space and a new hiring wave in South San Francisco or stays a one-off, high-profile tenant win. Newmark’s market overview notes positive net absorption and a shrinking construction pipeline in recent quarters, trends that could tighten conditions for top-tier lab real estate if they keep up.
